Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress.

IF 3 3区医学 Q2 INFECTIOUS DISEASES

European Journal of Clinical Microbiology & Infectious Diseases Pub Date : 2025-10-01 Epub Date: 2025-07-15 DOI:10.1007/s10096-025-05201-w

Defne Yigci, İlker Kayı, Yusuf Ziya Demiroğlu, Murat Kutlu, Zeki Kılıçaslan, Önder Ergönül

{"title":"Tuberculosis in Turkiye: Epidemiological insights and recommendations for progress.","authors":"Defne Yigci, İlker Kayı, Yusuf Ziya Demiroğlu, Murat Kutlu, Zeki Kılıçaslan, Önder Ergönül","doi":"10.1007/s10096-025-05201-w","DOIUrl":null,"url":null,"abstract":"Background: Tuberculosis (TB) remains a significant global public health challenge. We provide an overview of the current TB epidemiology in Turkey, highlighting key findings related to TB incidence, diagnostic challenges, and treatment outcomes.Results: A gradual decline in TB incidence in Turkiye has been observed over recent years. In 2022, the TB incidence rate was 11.5 per 100,000, falling short of achieving WHO's target of a 50% reduction by 2025. The prevalence of multidrug-resistant TB (MDR-TB) is rising, particularly among foreign-born populations, and delays in diagnosing extrapulmonary TB forms, such as TB meningitis and spondylodiscitis, continue to hinder effective treatment.Conclusion: We identify critical gaps in diagnostic tools, treatment adherence, and healthcare worker knowledge. We provide a set of comprehensive recommendations aimed at reducing TB incidence and improving treatment success, including the implementation of rapid molecular diagnostic tests, strengthening health policies for at-risk populations (such as migrants), improving healthcare worker education, and leveraging mobile health platforms to monitor treatment adherence.","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":" ","pages":"2323-2330"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology & Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10096-025-05201-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Tuberculosis (TB) remains a significant global public health challenge. We provide an overview of the current TB epidemiology in Turkey, highlighting key findings related to TB incidence, diagnostic challenges, and treatment outcomes.

Results: A gradual decline in TB incidence in Turkiye has been observed over recent years. In 2022, the TB incidence rate was 11.5 per 100,000, falling short of achieving WHO's target of a 50% reduction by 2025. The prevalence of multidrug-resistant TB (MDR-TB) is rising, particularly among foreign-born populations, and delays in diagnosing extrapulmonary TB forms, such as TB meningitis and spondylodiscitis, continue to hinder effective treatment.

Conclusion: We identify critical gaps in diagnostic tools, treatment adherence, and healthcare worker knowledge. We provide a set of comprehensive recommendations aimed at reducing TB incidence and improving treatment success, including the implementation of rapid molecular diagnostic tests, strengthening health policies for at-risk populations (such as migrants), improving healthcare worker education, and leveraging mobile health platforms to monitor treatment adherence.

查看原文本刊更多论文

土耳其的结核病：流行病学见解和进展建议。

背景：结核病（TB）仍然是一个重大的全球公共卫生挑战。我们概述了土耳其目前的结核病流行病学，重点介绍了与结核病发病率、诊断挑战和治疗结果有关的主要发现。结果：近年来观察到土耳其结核病发病率逐渐下降。2022年，结核病发病率为每10万人11.5例，未能实现世卫组织到2025年将发病率降低50%的目标。耐多药结核病（MDR-TB）的流行率正在上升，特别是在外国出生的人群中，并且诊断肺外结核形式（如结核性脑膜炎和脊柱炎）的延误继续阻碍有效治疗。结论：我们确定了诊断工具、治疗依从性和医护人员知识方面的关键差距。我们提供了一套旨在降低结核病发病率和提高治疗成功率的综合建议，包括实施快速分子诊断检测、加强针对高危人群（如移民）的卫生政策、改善卫生保健工作者教育以及利用移动卫生平台监测治疗依从性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Clinical Microbiology & Infectious Diseases 医学-传染病学

CiteScore

10.40

自引率

2.20%

发文量

138

审稿时长

1 months

期刊介绍： EJCMID is an interdisciplinary journal devoted to the publication of communications on infectious diseases of bacterial, viral and parasitic origin.